These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24442715)

  • 61. Nephrogenic fibrosing dermopathy, a new mimicker of systemic sclerosis.
    Dupont A; Majithia V; Ahmad S; McMurray R
    Am J Med Sci; 2005 Oct; 330(4):192-4. PubMed ID: 16234612
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biomarkers of skin and lung fibrosis in systemic sclerosis.
    Martinović Kaliterna D; Petrić M
    Expert Rev Clin Immunol; 2019 Nov; 15(11):1215-1223. PubMed ID: 31539483
    [No Abstract]   [Full Text] [Related]  

  • 63. A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.
    Taroni JN; Greene CS; Martyanov V; Wood TA; Christmann RB; Farber HW; Lafyatis RA; Denton CP; Hinchcliff ME; Pioli PA; Mahoney JM; Whitfield ML
    Genome Med; 2017 Mar; 9(1):27. PubMed ID: 28330499
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse.
    Ledein L; Léger B; Dees C; Beyer C; Distler A; Vettori S; Boukaiba R; Bidouard JP; Schaefer M; Pernerstorfer J; Ruetten H; Jagerschmidt A; Janiak P; Distler JHW; Distler O; Illiano S
    Br J Pharmacol; 2020 Sep; 177(18):4296-4309. PubMed ID: 32627178
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quantitative elastography provided by surface acoustic waves measured by phase-sensitive optical coherence tomography.
    Li C; Guan G; Cheng X; Huang Z; Wang RK
    Opt Lett; 2012 Feb; 37(4):722-4. PubMed ID: 22344160
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Limited impact of fibromodulin deficiency on the development of experimental skin fibrosis.
    Andréasson K; Gustafsson R; Rydell-Törmänen K; Westergren-Thorsson G; Saxne T; Hesselstrand R
    Exp Dermatol; 2016 Jul; 25(7):558-61. PubMed ID: 26997256
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An Ultrasound Surface Wave Technique for Assessing Skin and Lung Diseases.
    Zhang X; Zhou B; Kalra S; Bartholmai B; Greenleaf J; Osborn T
    Ultrasound Med Biol; 2018 Feb; 44(2):321-331. PubMed ID: 29195756
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detection of clonal T cells in the circulation of patients with nephrogenic systemic fibrosis.
    Kreuter A; Höxtermann S; Gambichler T; Tigges C; Hahn SA; Schieren G
    Arch Dermatol; 2009 Oct; 145(10):1164-9. PubMed ID: 19841405
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sclerodermalike syndromes: Great imitators.
    Varjú C; Kumánovics G; Czirják L; Matucci-Cerinic M; Minier T
    Clin Dermatol; 2020; 38(2):235-249. PubMed ID: 32513403
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Corticosteroids in Myositis and Scleroderma.
    Postolova A; Chen JK; Chung L
    Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Systemic sclerosis sine scleroderma.
    Kucharz EJ; Kopeć-Mędrek M
    Adv Clin Exp Med; 2017 Aug; 26(5):875-880. PubMed ID: 29068586
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combining optical coherence tomography with magnetic resonance angiography and Doppler ultrasonography for clinical detection of scleroderma.
    Zhang L; Li M; Liu Y; Zhou Q
    Anat Rec (Hoboken); 2020 Dec; 303(12):3108-3116. PubMed ID: 31854073
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches.
    Chairta P; Nicolaou P; Sokratous K; Galant C; Houssiau F; Oulas A; Spyrou GM; Alarcon-Riquelme ME; Lauwerys BR; Christodoulou K
    Arthritis Res Ther; 2020 May; 22(1):107. PubMed ID: 32381114
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Panniculitis-an unusual cutaneous manifestation of systemic sclerosis.
    Almeida MS; Lima SC; Carvalho LL; Almeida JV; Santos LG; Rolim JR; Rocha TE
    J Cutan Pathol; 2010 Nov; 37(11):1170-3. PubMed ID: 19615030
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The assessment of the patient with systemic sclerosis clinical course of the EUSTAR Budapest, January 13-16, 2005].
    Kucharz EJ
    Pol Arch Med Wewn; 2005 Oct; 114(4):1037-8. PubMed ID: 16789533
    [No Abstract]   [Full Text] [Related]  

  • 76. CCN proteins as potential actionable targets in scleroderma.
    Henrot P; Truchetet ME; Fisher G; Taïeb A; Cario M
    Exp Dermatol; 2019 Jan; 28(1):11-18. PubMed ID: 30329180
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis: role of gadolinium?].
    Kintossou R; D'Incan M; Chauveau D; Bens G; Franck F; Dauplat MM; Viraben R; Déchelotte P; Souteyrand P
    Ann Dermatol Venereol; 2007; 134(8-9):667-71. PubMed ID: 17925692
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nephrogenic systemic fibrosis: a histopathological study of eight cases of a recently described entity.
    Digby S; Macduff E; Blessing K; Holmes S
    Histopathology; 2008 Mar; 52(4):531-4. PubMed ID: 18315613
    [No Abstract]   [Full Text] [Related]  

  • 79. Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma.
    Higashi-Kuwata N; Makino T; Inoue Y; Takeya M; Ihn H
    Exp Dermatol; 2009 Aug; 18(8):727-9. PubMed ID: 19320738
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The contemporary management of systemic sclerosis.
    Eldoma M; Pope J
    Expert Rev Clin Immunol; 2018 Jul; 14(7):573-582. PubMed ID: 29874475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.